Are there vaccines for HCV or HIV?

Prepare for the AAMI Microbiology exam for embalmers with our comprehensive quiz. Use flashcards and multiple-choice questions with explanations and hints to master exam content and enhance your study experience.

Multiple Choice

Are there vaccines for HCV or HIV?

The main idea being tested is whether vaccines exist that are approved to prevent infection with hepatitis C virus (HCV) or human immunodeficiency virus (HIV). There are none. No licensed vaccine for HCV or HIV has completed regulatory approval, so the correct statement is that there are no approved vaccines for either virus. Understanding why helps. HCV and HIV pose distinct challenges that have blocked vaccine development. HCV mutates rapidly and exists as multiple genotypes, which makes it hard to create a single vaccine that provides broad protection. HIV is even more difficult because of its extreme genetic diversity, clever immune evasion strategies, and the way it establishes latent reservoirs in the body early after infection. These factors have kept vaccine candidates from achieving durable protection in trials, even though research continues. In contrast, there are effective treatments for HCV that can cure most people, but a preventive vaccine remains unavailable. For HIV, prevention currently relies on behavioral strategies, and pre-exposure prophylaxis (PrEP) with antiretrovirals—again, not a vaccine. So, while vaccines exist for some other viruses, at present there are no approved vaccines to prevent HCV or HIV infection.

The main idea being tested is whether vaccines exist that are approved to prevent infection with hepatitis C virus (HCV) or human immunodeficiency virus (HIV). There are none. No licensed vaccine for HCV or HIV has completed regulatory approval, so the correct statement is that there are no approved vaccines for either virus.

Understanding why helps. HCV and HIV pose distinct challenges that have blocked vaccine development. HCV mutates rapidly and exists as multiple genotypes, which makes it hard to create a single vaccine that provides broad protection. HIV is even more difficult because of its extreme genetic diversity, clever immune evasion strategies, and the way it establishes latent reservoirs in the body early after infection. These factors have kept vaccine candidates from achieving durable protection in trials, even though research continues. In contrast, there are effective treatments for HCV that can cure most people, but a preventive vaccine remains unavailable. For HIV, prevention currently relies on behavioral strategies, and pre-exposure prophylaxis (PrEP) with antiretrovirals—again, not a vaccine.

So, while vaccines exist for some other viruses, at present there are no approved vaccines to prevent HCV or HIV infection.

More practice questions